AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,000 | -48.6% | 1,300 | -16.1% | 0.07% | -56.9% |
| Q1 2019 | $74,000 | +42.3% | 1,550 | +6.9% | 0.16% | +45.5% |
| Q4 2018 | $52,000 | -29.7% | 1,450 | +20.8% | 0.11% | +5.8% |
| Q3 2018 | $74,000 | -8.6% | 1,200 | 0.0% | 0.10% | -29.7% |
| Q2 2018 | $81,000 | +50.0% | 1,200 | +20.0% | 0.15% | +55.8% |
| Q1 2018 | $54,000 | +200.0% | 1,000 | +233.3% | 0.10% | +458.8% |
| Q4 2017 | $18,000 | +20.0% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2017 | $15,000 | -6.2% | 300 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $16,000 | +14.3% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $14,000 | -97.0% | 300 | -97.6% | 0.01% | -97.2% |
| Q3 2016 | $472,000 | – | 12,500 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |